Glooko, a provider of remote patient monitoring and chronic care management solutions, has raised $30 million in a Series D round of funding.
The financing was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic.
Glooko will use the funding to accelerate organic growth and strategic initiatives across the company’s digital health solutions.
The new proceeds will accelerate execution of Glooko’s strategy, including increasing adoption of Glooko’s remote patient monitoring platform, widening commercialization of products in clinical research and expanding into additional therapy areas.
